Xenobiotic exposure activates or inhibits transcription of hundreds of protein-coding genes in 18 mammalian liver, impacting many physiological processes and inducing diverse toxicological 19 responses. Little is known about the effects of xenobiotic exposure on long noncoding RNAs 20 (lncRNAs), many of which play critical roles in regulating gene expression. Objective: to develop a 21 computational framework to discover liver-expressed, xenobiotic-responsive lncRNAs (xeno-lncs) 22 30 123 xeno-lncs were dysregulated by at least 10 chemicals, and 5 xeno-lncs responded to at least 20 of 31 the 27 chemicals investigated. 81 other xeno-lncs served as MOA-selective markers of xenobiotic 32 exposure. Xeno-lnc−protein-coding gene co-expression regulatory network analysis identified xeno-33 lncs closely associated with exposure-induced perturbations of hepatic fatty acid metabolism, cell 34 division, and immune response pathways. We also identified hub and bottleneck lncRNAs, which are 35 expected to be key regulators of gene expression in cis or in trans. This work elucidates extensive 36 networks of xeno-lnc−protein-coding gene interactions and provides a framework for understanding 37 the extensive transcriptome-altering actions of diverse foreign chemicals in a key responsive 38 mammalian tissue. 39 40 65
with strong functional, gene regulatory potential and elucidate the impact of xenobiotic exposure on 23 their gene regulatory networks. We analyzed 115 liver RNA-seq data sets from male rats treated with 24 27 individual chemicals representing seven mechanisms of action (MOAs) to assemble the long non- 25 coding transcriptome of xenobiotic-exposed rat liver. Ortholog analysis was combined with co-26 expression data and causal inference methods to infer lncRNA function and deduce gene regulatory 27 networks, including causal effects of lncRNAs on protein-coding gene expression and biological 28 pathways. We discovered >1,400 liver-expressed xeno-lncs, many with human and/or mouse 29 orthologs. Xenobiotics representing different MOAs were often regulated common xeno-lnc targets:
Introduction 41 Many industrial chemicals, drugs, environmental toxicants, and other foreign chemicals, collectively 42 known as xenobiotics, have adverse effects on humans and other species [1, 2] . Mammalian liver is a 43 key xenobiotic-responsive tissue: it undergoes major changes in gene expression and the epigenetic 44 landscape, which impacts many biological pathways and induces diverse toxicological responses. 45 Many of these responses are mediated by nuclear receptors or other transcription factors that bind 46 foreign chemicals directly, or whose activity is indirectly altered by xenobiotic exposure [3] or by 47 other mechanisms of action (MOAs) [4] [5] [6] . Elucidation of the gene targets, gene expression networks, 48 and MOAs of xenobiotics is critical for the evaluation and interpretation of toxicological outcomes 49 and hazard risk assessment. 50 Long noncoding RNAs (lncRNAs) comprise a significant fraction of the mammalian transcriptome and 51 are often expressed in a highly tissue-specific or condition-dependent manner. LncRNAs act by 52 diverse mechanisms to exert regulatory effects [7] , including transcriptional, epigenetic and 53 translational control of gene expression [8] . Many lncRNA genes are responsive to endogenous 54 hormones [9, 10] or to environmental factors in mouse liver, as we recently observed in mice 55 exposed to TCPOBOP, an agonist ligand of the nuclear receptor constitutive androstane receptor 56 (CAR) [11] . It is unclear, however, whether lncRNAs respond to xenobiotics that activate receptors 57 controlling other biological pathways, such as peroxisome proliferator-activated receptor  or  58 (PPARA, PPARG), estrogen receptor (ER), and aryl hydrocarbon receptor (AhR), or to xenobiotics that 59 act by other MOAs, including DNA damage or cytotoxicity (Scheme 1). LncRNA responses to chemical 60 exposures may be MOA-specific, or alternatively, lncRNAs may respond in common to diverse 61 chemicals that act via distinct MOAs. Further, the biological pathways associated with xenobiotic-62 responsive lncRNAs are almost totally unknown. Gain-of-function [12] and loss-of-function studies 63 [13] have been used in cell culture screens to identify lncRNAs required for cell growth and drug 64 resistance [13, 14] , but such screens are not readily implemented in intact animal models. Given the Sequence reads were mapped to the rat genome (rn6) [16] using TopHat2 [17] with default 83 parameters, including multi-mappable reads. Mapping rates ranged from 65-95% across samples. 84 Cufflinks and Cuffmerge [18] were used to assemble a transcriptome comprised of both coding and 85 non-coding transcripts. Transcript annotation for lncRNAs was based on three key features: transcript 86 length >200 nt, low or no coding potential, and absence of overlap with known protein-coding genes 87 (PCGs) [19] . Two approaches were used for lncRNAs discovery. Approach 1 [9]: First, transcripts that 88 do not contain the above three key lncRNA features were filtered out. Thus, the 144,636 rat liver 89 transcripts generated by Cufflinks were scanned for genes that overlap known RefSeq gene 90 annotations. Transcripts exhibiting similarities to PCGs based on their coding potential and codon 91 degeneracy were removed. Transcripts were converted into mature RNA sequences by exon 92 concatenation, translated using all six open reading frames, then evaluated for the presence of 93 protein-domain like regions (Pfam) using HMMER [20] . PhyloCSF [21] was used to identify 94 evolutionary signatures with characteristic alignments of conserved coding regions and to distinguish 95 PCGs from non-coding lncRNAs based on synonymous codon substitution frequencies and 96 conservative amino acid substitutions. The coding potential of each genomic region was evaluated 97 based on a log-likelihood ratio: transcripts with a positive score have an increased likelihood of 98 coding for a functional protein and were discarded. The second filter excluded transcripts expressed 99 below a fragment per kilobase length per million sequence reads (FPKM) cutoff tailored for each 100 RNA-seq sample, which are likely to have truncated gene boundaries [9] . Genes longer than 200 nt 101 were retained in the final set of rat liver lncRNAs. Approach 2: We used the lncRNA discovery tool 102 Slncky [22] to identify an initial set of lncRNAs from the same 115 RNA-seq samples, filtered to 103 remove known pseudogenes, PCGs, and artifacts from transcript assembly, and then assessed the 104 coding potential for small peptides or novel proteins. Slncky excludes transcripts that overlap 105 unannotated PCGs or incomplete transcripts that align to untranslated region sequences. Next to characterize the conservation properties of lncRNA orthologs: transcript-genome identity (TGI;   133 percent of identical, aligning nt between a rat lncRNA and a non-transcribed locus in a syntenic region in 134 the mouse, or human, genome); and transcript-transcript identity (TTI; percentage of identical, aligning 135 nt present in the exonic regions of lncRNAs in both species). A TGI or TTI threshold of 30% conservation 136 of the rat lncRNA sequence was used to define lncRNA orthologs. Putative functions for rat lncRNAs 137 were deduced from GENCODE or NONCODE annotations [29] or from our PubMed searches for the 774 138 of 1,447 rat liver xeno-lncs that shared orthology with mouse lncRNAs (267 orthologs), human lncRNAs 139 (179 orthologs), or both mouse and human lncRNAs (328 orthologs) ( Table S4 ). 140 rat-mouse lncRNA 140 ortholog pairs that respond to CAR or PXR in both species were identified as follows. First, we 141 considered the set of 2,029 CAR/PXR-responsive rat liver lncRNAs defined at a relaxed threshold of 142 |FC|>2 at FDR <0.05 (Table S5A ). Of these, 381 are orthologous to one of the 15,558 mouse liver-143 expressed lncRNAs that we described earlier [10, 11] . Next, we identified the subset of these 381 144 CAR/PXR-responsive rat xeno-lncs that is found in at least one of two sets of CAR/PXR-responsive 145 mouse liver lncRNAs, which we discovered by analyzing published RNA-seq data for expression of the 146 above 15,558 mouse liver-expressed lncRNAs. Set 1 = 1,166 mouse liver lncRNAs that respond at |FC|>2 147 at FDR <0.05 to either pregnenolone 16α-carbonitrile (mouse PXR activator) or TCPOBOP (mouse CAR 148 activator, after 3 or 27 h) [11]; and Set 2 = 1,339 mouse liver lncRNAs that respond at |FC| >2 and FDR 149 <0.05 to TCPOBOP or to the human CAR activator CITCO after a multi-day exposure in mice at either 5 150 or 60 days of age (GSE98666) [30] (Table S5B) . A total of 140 CAR/PXR-responsive rat lncRNAs had a 151 mouse ortholog that responded to CAR or PXR activation in at least one of the mouse datasets (Table   152 S5C).
153
Tissue-specific co-expression networks -We used two complementary methods that employ 154 hierarchical clustering based on gene co-expression data to assign co-regulated rat liver lncRNAs and 155 PCGs to co-expression network modules. Weighted Gene Co-expression Network Analysis (WGCNA) 156 [31] uses an agglomerative (bottom-up) clustering approach starting with a similarity matrix S, which 157 is comprised of Pearson correlation values for each gene pair i and j, defined as sij= |cor(i,j)|. We 158 transformed the similarity matrix into an unsigned adjacency matrix A by raising the correlation 159 values to a power ('soft' threshold): aij = sβij with β≥1. The power β, which produces a higher 160 similarity with a scale−free network, was used to emphasize strong correlations and punish weak 161 correlations on an exponential scale. We selected the parameter β=12 using the pickSoftThreshold 162 function in the WGCNA R package. Next, the adjacency matrix was converted into a distance measure 163 (dissTOM = 1-Topological Overlap Matrix), which calculates the edge weight between two nodes 164 based on its network neighbors and minimizes the effects of noise and spurious associations [32] . 165 Ultimately, we identified eight rat liver xeno-gene/xeno-lnc co-expression modules ( Table S6A ) by 166 applying the branch cutting method dynamic TreeCut [33] . WGCNA is superior in finding biological 167 relevant modules, but has two major limitations: modules are often large, which complicates 168 downstream refinement of biological processes; and each gene can only be assigned to a single 169 module, which may not fully capture the complex biology, where individual genes play essential roles 170 in more than one biological process. The second method, Multiscale Embedded Gene Co-expression 171 Network Analysis (MEGENA) [34], addresses these limitations and generates more compact and more 172 coherent modules, where genes can be assigned to multiple modules. MEGENA uses a divisive (top-173 down) approach based on the shortest path distance measure and k-medoids clustering, which finds 174 k optimal clusters at each step by minimizing the distance within each cluster to define a more 175 compact gene set. The clustering process continues until no further compact child clusters are 176 formed. We used the R package MEGENA to discover 89 compact modules using the 2,637 significant 177 PCGs and 1,447 significant xeno-lncs as input ( Figure S1 , Table S6B ). (2,637) to learn the causal structure, which is a completed partially directed acyclic graph (CPDAG). 217 The analysis starts with a fully connected undirected graph and then determines if an edge is to be 218 removed from or retained in the graph by conducting conditional independence tests for the two 219 nodes connected by the edge. We used partial correlations for the conditional independence test 220 6
[52]. The algorithm then orients the CPDAG, which consist of directed and undirected edges, resulting 221 in the equivalence class of directed acyclic graphs. The pcalg package in R was used to estimate 222 CPDAG with a significance level (α = 0.01) for the CI test conducted by ParallelPC algorithm.
Step 2: 223 The causal effect of a lncRNA on a PCG was estimated by applying do-calculus, which when given a 224 directed acyclic graph, estimates the causal effect of one node on any other node using observational 225 data. Since multiple directed acyclic graphs (described above) resulted from CPDAG, we estimated (Table S8) . 
Results
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Liver xeno-lnc discovery -We reconstructed the transcriptome for xenobiotic-exposed rat liver based 235 on 115 RNA-seq datasets from male Sprague-Dawley rats given one of 27 chemicals representing 236 seven distinct MOAs (Table S1 ). We used two complementary approaches (see Methods) to discover 237 a total of 5,795 liver-expressed lncRNA genes, of which 37% are multi-exonic genes (Table S2) . 1,447 238 of the lncRNAs showed significant differential expression (|FC| >4 at FDR < 0.05) following exposure 239 to one or more of the 27 chemicals, and were designated xeno-lncs (Table S3A ). We also identified 240 2,637 PCGs responsive to these exposures (Table S3B ). AhR and the non-receptor based MOAs formed incohesive clusters (Figures 2A, 2B) . Thus, the six 250 CAR/PXR activators were separated into three separate clusters, as were the three DNA damage 251 agents, and the AhR agonist leflunomide induced gene expression changes distinct from those 252 induced by the two other AhR activators for both lncRNAs and PCGs. This likely reflects the diversity 253 of mechanisms through which some of these chemicals act, e.g., leflunomide can also activate MAP 254 kinases and induce endoplasmic reticulum stress [55] . We found 66 PCGs and 32 xeno-lncs that 255 responded significantly to at least two of the three AhR agonists ( Table S3C) were also dysregulated across ≥20 exposures (Figure 2E , Table S9 ). Again, gene responses to the two 265 specific AhR agonists were similar to responses induced by aflatoxin B1 but not leflunomide. Xeno-266 lncs and PCGs whose expression is dysregulated by multiple chemical exposures with distinct MOAs 267 may be associated with general responses, such as liver injury or tissue repair stimulated by 268 xenobiotic exposure. Two of the 13 PCGs, Sult2a2 (Figure S2B) and Ugt1a2, metabolize xenobiotics 269 and were consistently up-regulated, while 3 other PCGs, Ltc4s (Figure S2B) (Figure 3A) . Some of these orthologs are well-characterized functional lncRNAs. For instance, rat 303 xeno-lnc rlnc449, which is induced by HMG-CoAR inhibitors and cytotoxicity and DNA damage agents 304 but is repressed by several activators of CAR/PXR, PPAR and ER, showed 64% sequence identity with 305 human lncRNA H19, both at the transcript level (TTI) and at the genome level (TGI) (Figure 3B) . 306 LncRNA H19 is important for fetal liver development and is repressed after birth, but is over-307 expressed in multiple human cancers, including hepatocellular carcinoma, where it enhances tumor 308 progression [65, 66]. Another rat liver xeno-lnc, rlnc397, which is induced by several nuclear 309 receptors agonists and by the hepatoxin carbon tetrachloride, shares 66% TTI with mouse lncRNA 310 Snhg14 (Figure 3C) . Snhg14 is overexpressed in several cancers and potentiates tumor progression, in 311 humans, by serving as a sponge (endogenous competitor RNA) for multiple microRNAs [67-69]. Table   312 S4 presents the full set of rat lncRNA orthologs and their inferred functions.
313
Rat-Mouse ortholog responses to CAR/PXR activators -We identified 140 rat xeno-lncs with mouse 314 orthologs that responded to at least one CAR/PXR activator in both mouse and rat liver. Two−way 315 hierarchical clustering of expression data across exposures indicates species is a dominant separation 316 factor (Figure S4A) . Some lncRNAs showed a consistent pattern of dysregulation in both species 317 (rlnc4048−mlnc4655, both up ( Figure S4B) ; and rlnc4100−mlnc4577, both down (Figure S4C) ), while 318 others showed opposite regulation (rlnc2209-mlnc3859; Figure S4D ). Some xeno-lncs were 319 responsive to CAR activators after multiple days of exposure, e.g., rlnc1448−mlnc2065, which 320 responded to CAR activators significantly (|FC| >2, FDR <0.05) in both species after a 4-5-day 321 exposure, but not after 1 day in mouse liver (Figure S4E, Table S5C ). Thus, xeno-lncs perturbed by (Table S6A, S6B) . For each co-expression network, we identified rat lncRNAs whose 335 orthologs have functional annotations, including oncogenic gene drivers and tumor suppressors. We 336 also computed module functional enrichments to obtain a primary level of annotation for lncRNA 337 function. These lncRNA−PCG networks helped us identify many highly connected lncRNAs in each 338 module, including intra-modular hubs and bottleneck genes, which are at critical nodes controlling 339 communication among other nodes in the network, as indicated by a high number of non−redundant 340 shortest paths through the specific node or edge [44] . We discovered co-expressed modules with 341 striking functional enrichments for genes in multiple biological processes and pathways, including 342 fatty acid metabolism (MEGENA module C9), lipid and sterol metabolism (module Black), cell cycle 343 (module C13) and immune response (module C7) (Table S11, Table S12 ). One module, C10 (68 PCGs, 344 91 xeno-lncs), did not show any significant biological or pathway enrichment, but contains all 50 ER 345 marker genes. The eleven xeno-lncs identified as hub or bottleneck genes in this module are 346 suggested to play a regulatory role in estrogen-based pathways (Figure S5, Table S12A ). Highlights of 347 select gene modules are presented below. Table S11E ). This module is also strongly enriched for 351 peroxisomal genes (ES=13.0) and harbors 35 of the 39 (90%) PPAR marker genes. Seven xeno-lncs 352 were either top intra-modular hubs, bottlenecks, or both (Figure 4, Figure S6 , Table S12B) (Table S12B ), and five of these genes (Cyp2j4, Acat1, Acaa1a, Ucp3, Acox1) are PPAR 359 MOA-selective marker genes (Table S10) . 360 Xeno-lncs associated with cell cycle regulatory genes -Module C13, comprised of 106 PCGs and 6 361 xeno-lncs, includes 87 PCGs (82%) involved in cell cycle pathways (Figure 5A, Table S12C ). The strong 362 enrichment of this module for cell cycle and cell division genes (ES= 17.7) and for microtubule 363 binding, spindle, kinesin and related terms (ES=7.6) (Table S11H) implicates the six lncRNAs in this 364 module in these processes. One, xeno-lnc rlnc3347, is orthologous with NORAD, a human lncRNA that 365 is up-regulated by DNA damage, maintains chromosomal stability in human cells, and is implicated in (Table   378 S11D, Table S12D ). This module includes 94 xeno-lncs, of which three are hub genes (rlnc2830, (Figure 6B, Table S14A ). N-nitrosodimethylamine also up-regulated 112 (64%) of the 125 oncogenic 386 driver or suppressor genes in module C7 ( Table S14B ). The hub gene rlnc1130 was connected to six 387 genes in module C7, while hub−bottleneck rlnc1023 made connections with a partially overlapping 388 set of nine genes ( Figure 6C) . rlnc1023 negatively correlated with Arg1, an immunosuppressive gene 389 [82], and with Emp2, a tumor suppressor (Li et al. 2013 ). These two regulatory xeno-lncs were 390 negatively correlated with Sox4, a heptaocarcinogenic driver [83], and showed positive associations 391 with Il6R and Mat1a. Miconazole, an antifungal agent and CAR/PXR agonist, significantly repressed 392 both regulatory xeno-lncs and seven of the PCGs, while strongly inducing three others, including 393 S100a6 (Figure 6D) . Increased expression of S100a6 promotes cell proliferation in human HCC [84] . 394 Overall, 50 xeno-lncs from module C7 showed either positive or negative associations with 125 395 oncogenic drivers or suppressors (Table S14B). Chemicals that dysregulate these xeno-lncs are 396 expected to have a major impact on tumorigenesis. Table S3A) . (Figure 8A) . However, rlnc1425 also showed casual, negative correlation with metallothioneins 420 Mt1a and Mt2a, which protect mice from hepatocarcinogen-induced liver damage and carcinogenesis 421 [90] and are induced in rat liver, up to 16-fold, by the three ER agonists and by leflunomide (AhR) and 422 econazole (CAR/PXR) ( Table S15A) (Figure 8A, Table S15B ). 426 Expression of rlnc2750, which was down-regulated by 21 chemicals, was positively associated with 427 the tumor suppressors Igfals [91] and Bmf [92] (Figure 8B) , which were also down-regulated by 428 multiple chemicals (Table S15C) (Table S15D) . 437 The fifth lncRNA consistently down-regulated by >20 chemicals, rlnc4657, is in module C12, where it 438 forms positive causal associations with three PCGs down-regulated by multiple chemicals (Apoc3, 439 St8sia1, Gimd1) ( Figure 8D, Table S15E ). Apoc3 contributes to cardiovascular disease risk by 440 increasing plasma triglycerides via lipolysis of triglyceride-rich lipoproteins [97], and its repression by 441 PPAR activators is therapeutically beneficial. Gimd1, whose function is unknown, also showed strong, 442 consistent repression by PPAR activators (log2 FC = -5 to -7) ( Table S3B) (Figure 1) . We applied this framework to a rich toxicogenomic dataset comprised of 115 477 RNA-seq datasets representing 27 chemical exposures in a rat model [6] to assemble the toxico-478 transcriptome of liver, a key tissue for xenobiotic metabolism and toxification/detoxification. We 479 discovered gene and isoform structures for almost 6,000 liver-expressed rat lncRNAs, a majority of 480 which are novel genes, and established expression patterns for more than 1,400 xenobiotic-481 responsive lncRNAs (xeno-lncs), many with human and/or mouse orthologs. Further, we used two 482 powerful data-driven approaches for co-expression analysis, WGCNA [31] and MEGENA [34], to 483 discover xenobiotic-responsive gene modules enriched in various cellular processes, including fatty 484 acid and sterol metabolism, cell cycle and immune response. Xeno-lncs occupying key positions as 485 hubs or bottleneck genes were identified in the derived networks, and causal inference was used to 486 identify xeno-lncs that causally influence expression of their target genes, i.e., are causal regulators of 487 the biological network. Thus, we present a comprehensive toxicogenomic analysis of the effects of 488 foreign chemicals on the non-coding transcriptome, and we elucidate xenobiotic-responsive 489 regulatory lncRNAs for key biological pathways commonly perturbed in xenobiotic-exposed liver. 490 We used two complementary approaches for lncRNA discovery [9, 22] to increase the likelihood of 491 discovering novel liver-expressed lncRNAs. 1,447 of the 5,795 rat liver-expressed lncRNAs identified 492 were characterized as xeno-lncs based on their responsiveness to one or more xenobiotic exposures. 493 We applied a relatively stringent threshold (>4-fold increase or decrease in expression at FDR <0.05) 494 to reduce false positives resulting from transcriptional noise from lncRNAs expressed at a low level. 495 The set of 1,447 xeno-lncs discovered here is defined by the transcriptional responses stimulated by 496 the 27 chemical exposures included in our analyses, and should thus be viewed as a minimal xeno-lnc 497 gene set. Additional xeno-lncs are very likely to be discovered and their gene structures and isoform 498 models further refined once expression data for additional xenobiotic exposure datasets become 499 available and can be integrated into the liver toxico-transcriptome presented here. 500 We found 81 xeno-lncs and 81 xenobiotic-responsive PCGs that were primarily associated with 501 chemicals linked to a single MOA (xenobiotic MOA-selective marker genes; Table S10 ). We also 502 found, however, that many xeno-lncs responded in common to multiple xenobiotics encompassing 503 multiple MOAs. For example, 123 xeno-lncs each responded to at least 10 different chemicals ( Figure   504 2D), i.e., they respond via at least two different MOAs. While some of these xeno-lncs respond to 505 chemicals that activate mechanistically related MOAs with overlapping target gene specificities (e.g., Agonists of AhR, and the hepatotoxic chemical aflatoxin B1, which also has AhR agonist activity [56], 523 often showed effects that were opposite of chemicals that act via other MOAs, most notably for 524 chemicals that activate PPAR (Figure 2C) . For example, the xenobiotic-metabolizing P450 enzyme 525 Cyp2b1 was induced by 5 of 6 PPAR agonists (Table S3C) but was repressed by all three AhR agonists, 526 while Acot1, a PPAR target and a key player in rodent liver tumorigenesis [109], was up-regulated by 527 22 chemicals but not by the AhR agonists or by aflatoxin−B1. Similarly, we found five xeno-lncs that 528 were each down-regulated by at least 20 of the 27 chemicals examined, but did not respond to the 529 AhR agonists -naphthoflavone and 3-methylcholanthrene. Mechanistic studies will be required to 530 elucidate the mechanism for these disparate responses to activation of AhR vs. other MOAs. 531 In some cases, xeno-lnc orthologs showed significant species-specific responses to chemical 532 exposures. Thus, many of the 140 orthologous pairs of rat and mouse lncRNAs that responded to 533 CAR/PXR activators showed species-specific responses. This finding parallels the species difference in 534 xenobiotic responses sometimes seen for orthologous PCGs (Figure S4) , which may reflect factors 535 such as species differences in the specificity of xenobiotic receptors for agonists and/or their target 536 genes [30, [110] [111] [112] . This potential for species-dependent responses must be considered when 537 evaluating lncRNA orthologs and their biological activities. 538 We built gene co-expression networks (gene modules) based on gene co-expression patterns for 539 xeno-lncs and xenobiotic-responsive PCGs across the 27 xenobiotic exposures, and then used the 540 associations between xeno-lncs and PCGs within the networks to infer the functions of liver-541 expressed xeno-lncs (guilt-by-association). Networks were reconstructed using WGCNA, which is 542 widely used [10, 113-115], and using a complementary approach, MEGENA, which has identified 543 mutational drivers in non-alcoholic fatty liver disease [116, 117] . Many of the gene modules we 544 discovered were enriched in specific biological functions, including fatty acid metabolism, cell 545 division, and immune response pathways. In some cases, MOA marker genes were grouped in a 546 common module based on their coordinated co-regulation pattern (e.g., ER marker genes in module 547 C10; Figure S5 ). We also implemented network modeling to identify hub or bottleneck genes that (Figure 4) . This validation of our approach lends support 552 for the roles we propose for key xeno-lncs identified as hubs or bottlenecks in these biological 553 processes and pathways. Key findings include the discovery of novel regulatory xeno-lncs that were 554 co-expressed with tumor suppressors or cancer drivers in the immune response module C7 ( Figure   555 S8) or that occupied critical positions in networks enriched for fatty acid metabolism (Figure 4) , viral 556 response and sterol metabolism (Figure 7) . In many cases, our findings were strengthened by using 557 Parallel IDA, a causal inference algorithm [120-122], which can help distinguish true, causal regulatory 558 relationships from simple correlative associations , as summarized in Table S16A . 559 Ortholog analysis, based on either sequence conservation or synteny [123] , can facilitate discovery of 560 biologically relevant properties of lncRNAs [124] . We used this approach to identify rat xeno-lncs 561 showing conservation with known oncogenic lncRNAs, including H19 (rlnc449), LINC00665 (rlnc5324) 562 [125], SNHG20 (rlnc 3767) [ (Table S14B) . Supporting this finding, the module C7 co-expression network containing rlnc1439 568 ( Figure S8B) shows positive correlation between rlnc1439 and S100a11, which is overexpressed in 569 many human cancers [128] , and also with Sox4, which promotes hepatocarcinogenesis by inhibiting 570 p53-mediated apoptosis [83] . 571 In conclusion, we present a novel approach to discover xenobiotic-responsive lncRNAs and obtain 572 important insights into their roles in diverse cellular processes, the biological pathways they impact 573 and their effects on hepatic responses to xenobiotic exposures. The computational framework that 574 we propose (Figure 1) Chemicals are color−coded by MOA, which is indicated following the abbreviated chemical names 924 (see Table S1 
